Doseology Sciences Inc. (DOSEF)
USD 0.14
(0.0%)
USD 0.14
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -1.72 Million CAD | 58.03% |
| 2021 | -1.67 Million CAD | -13.51% |
| 2020 | -1.47 Million CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | -138.07 Thousand CAD | -129.71% |
| 2023 Q1 | -60.1 Thousand CAD | 47.55% |
| 2022 FY | - CAD | 58.03% |
| 2022 Q3 | -59.07 Thousand CAD | 75.26% |
| 2022 Q2 | -238.75 Thousand CAD | 17.27% |
| 2022 Q1 | -288.6 Thousand CAD | 35.88% |
| 2022 Q4 | -114.6 Thousand CAD | -93.99% |
| 2021 Q3 | -485.56 Thousand CAD | -3.47% |
| 2021 Q1 | -262.77 Thousand CAD | 54.68% |
| 2021 Q2 | -469.29 Thousand CAD | -78.59% |
| 2021 Q4 | -450.1 Thousand CAD | 7.3% |
| 2021 FY | - CAD | -13.51% |
| 2020 Q4 | -579.82 Thousand CAD | -57.92% |
| 2020 Q3 | -367.15 Thousand CAD | 5.06% |
| 2020 Q2 | -386.72 Thousand CAD | -180.78% |
| 2020 Q1 | -137.72 Thousand CAD | 0.0% |
| 2020 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 97.573% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 70.922% |
| SQZ Biotechnologies Company | -64.14 Million USD | 97.312% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 90.075% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 101.833% |
| Mesoblast Limited | -62.38 Million USD | 97.237% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -12.237% |
| Genus plc | 73.7 Million USD | 102.339% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 73.924% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | 51.395% |
| Marizyme, Inc. | -34.28 Million USD | 94.971% |
| ContraFect Corporation | -64.99 Million USD | 97.348% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 80.346% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 61.91% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -22.985% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | 34.806% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | 25.811% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -232.791% |
| Accustem Sciences Inc. | -3.74 Million USD | 53.982% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 96.425% |
| EV Biologics, Inc. | -1.26 Million USD | -36.056% |
| Q BioMed Inc. | -617.62 Thousand USD | -179.135% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 148.265% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -172.612% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | 24.534% |
| Biomind Labs Inc. | -1.03 Million USD | -66.644% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 117.455% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 75.926% |
| Skye Bioscience, Inc. | -13.54 Million USD | 87.274% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -15.907% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -6796.052% |
| Arch Therapeutics, Inc. | -3.88 Million USD | 55.616% |
| IMV Inc. | -35.52 Million USD | 95.147% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 89.136% |
| Curative Biotechnology, Inc. | -2.5 Million USD | 31.094% |
| GB Sciences, Inc. | -1.41 Million USD | -21.419% |
| Alpha Cognition Inc. | -9.7 Million USD | 82.237% |
| HST Global, Inc. | -5303.00 USD | -32410.145% |
| CSL Limited | 4.78 Billion USD | 100.036% |
| Halberd Corporation | -74.27 Thousand USD | -2220.997% |
| Enzolytics Inc. | -2.12 Million USD | 18.756% |
| Resverlogix Corp. | -11.74 Million USD | 85.318% |
| Affymax, Inc. | -14.29 Million USD | 87.94% |
| SYBLEU INC | -141.57 Thousand USD | -1117.773% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | 43.715% |
| argenx SE | -216.02 Million USD | 99.202% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 96.885% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 241.661% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -15.018% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 555.072% |
| AVAX Technologies, Inc. | -6.11 Million USD | 71.796% |
| Zenith Capital Corp. | -8.6 Million USD | 79.967% |
| Genscript Biotech Corporation | -248.71 Million USD | 99.307% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -9796.177% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | 29.53% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -879.417% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 95.65% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | 40.394% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -64.77% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 25739.694% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | 1.485% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | 10.25% |
| BioStem Technologies, Inc. | -7.55 Million USD | 77.176% |
| ONE Bio Corp. | 13.61 Million USD | 112.664% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -852.031% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | 16.188% |
| Agentix Corp. | -1.37 Million USD | -25.679% |
| LadRx Corporation | 412.28 Thousand USD | 518.163% |
| Cell Source, Inc. | -4.27 Million USD | 59.649% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -369.476% |
| Regen BioPharma, Inc. | 1.46 Million USD | 217.603% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -84.003% |
| NovAccess Global Inc. | -1.03 Million USD | -66.604% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 119.472% |
| Itoco Inc. | -1.86 Million USD | 7.757% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -354.142% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -54.481% |
| Kadimastem Ltd | -2.62 Million USD | 34.308% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -620.892% |
| CytoDyn Inc. | -18.02 Million USD | 90.438% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -2081.494% |
| Mobile Lads Corp. | -2.24 Million USD | 23.075% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -13997.743% |
| Qrons Inc. | -40.08 Thousand USD | -4201.322% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -254.97% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 426.869% |
| Rebus Holdings, Inc. | -951 Thousand USD | -81.284% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -62.335% |
| International Stem Cell Corporation | 202 Thousand USD | 953.472% |
| Bioxytran, Inc. | -3.82 Million USD | 54.871% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -3175.101% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | 29.973% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 95.194% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -3731.14% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | 37.034% |
| Neutra Corp. | -181.24 Thousand USD | -851.195% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 91.448% |
| PureTech Health plc | -11.62 Million USD | 85.172% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 91.447% |
| IXICO plc | -707 Thousand USD | -143.849% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 77.567% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 96.434% |
| CSL Limited | 4.73 Billion USD | 100.036% |
| Cellectis S.A. | -92.63 Million USD | 98.139% |